FDA.reportPublic FDA data

acetaminophen 250 MG / aspirin 250 MG / caffeine 65 MG Oral Tablet [Arthriten Inflammatory Pain]

RxCUI
1303159
RxNorm name
acetaminophen 250 MG / aspirin 250 MG / caffeine 65 MG Oral Tablet [Arthriten Inflammatory Pain]
Display name
ARTHRITEN INFLAMMATORY PAIN (Oral Pill)
Full name
acetaminophen 250 MG / aspirin 250 MG / caffeine 65 MG Oral Tablet [Arthriten Inflammatory Pain]
Term type
SBD
Status
Active
Strength
250-250-65 mg
Dose form
Tab
Route
Oral Pill
Updated
2026-07-21 06:55:59

RxNorm Status History#

Status
Active
Source
RXNORM
Current
YES
Release start
082012
Active start
082012
Multiple ingredient
YES
Branded
YES

Ingredients And Strength#

Ingredient, Strength, Base table
IngredientStrengthBaseBasis of strength
aspirin250 MG / 1 EACHaspirinaspirin
acetaminophen250 MG / 1 EACHacetaminophenacetaminophen
caffeine65 MG / 1 EACHcaffeinecaffeine

Dose Form Concepts#

Dose form, RxCUI table
Dose formRxCUI
Oral Tablet317541

Derived Ingredient Concepts#

Ingredient, RxCUI table
IngredientRxCUI
aspirin1191
acetaminophen161
caffeine1886

Source Vocabulary Codes#

Code type, Value, Category table
Code typeValueCategory
PRESCRIBABLEYATTRIBUTES
RXNAV_STRAPAP 250 MG / ASA 250 MG / Caffeine 65 MG Oral Tablet [Arthriten Inflammatory Pain]NAMES
RxNorm Nameacetaminophen 250 MG / aspirin 250 MG / caffeine 65 MG Oral Tablet [Arthriten Inflammatory Pain]NAMES
RxNorm SynonymAPAP 250 MG / ASA 250 MG / Caffeine 65 MG Oral Tablet [Arthriten Inflammatory Pain]NAMES
RxNorm SynonymArthriten Inflammatory Pain (APAP 250 MG / ASA 250 MG / caffeine 65 MG) Oral TabletNAMES
TTYSBDATTRIBUTES
SPL_SET_IDc280ca89-4fb5-4050-90ee-d706a550a1efCODES
RxCUI1303159CODES
MMSL_CODEBD3844CODES

FDA NDC Products And Packages#

Package NDC, Product NDC, Name table
Package NDCProduct NDCNameLabelerApplication
52389-237-2852389-237Arthriten acetaminophen, aspirin, caffeineKobayashi Healthcare International, IncM013

Drugs@FDA Applications#

Application, NDC, Name table
ApplicationNDCNameMarketing categoryLabeler
M01352389-237Arthriten acetaminophen, aspirin, caffeineOTC MONOGRAPH DRUGKobayashi Healthcare International, Inc

RxNav Current And Historical NDCs#

NDC11, Source, Active table
NDC11SourceActive
52389023701rxnav_ndcsyes
52389023728rxnav_ndcsyes

DailyMed RxNorm Mappings#

Set ID, RxNorm string, TTY table
Set IDRxNorm stringTTYSPL versionLabelEffective
c280ca89-4fb5-4050-90ee-d706a550a1efacetaminophen 250 MG / aspirin 250 MG / caffeine 65 MG Oral Tablet [Arthriten Inflammatory Pain]SBD13Arthriten Inflammatory Pain Formula20250411
c280ca89-4fb5-4050-90ee-d706a550a1efARTHRITEN Inflammatory Pain Formula 250 MG / 250 MG / 65 MG Oral TabletPSN13Arthriten Inflammatory Pain Formula20250411
c280ca89-4fb5-4050-90ee-d706a550a1efArthriten Inflammatory Pain (APAP 250 MG / ASA 250 MG / caffeine 65 MG) Oral TabletSY13Arthriten Inflammatory Pain Formula20250411
c280ca89-4fb5-4050-90ee-d706a550a1efAPAP 250 MG / ASA 250 MG / Caffeine 65 MG Oral Tablet [Arthriten Inflammatory Pain]SY13Arthriten Inflammatory Pain Formula20250411

DailyMed Labels#

Set ID, Title, Manufacturer table
Set IDTitleManufacturerEffective
c280ca89-4fb5-4050-90ee-d706a550a1efArthriten Inflammatory Pain FormulaKobayashi Healthcare International, Inc | Kobayashi America Manufacturing, LLC20250411

Drug Classes#

Source, Class ID, Class table
SourceClass IDClassTypeRelationshipDrug concept
ATCN02BEAnilidesATC1-4acetaminophen
ATCA01ADOther agents for local oral treatmentATC1-4aspirin
ATCD11AXOther dermatologicalsATC1-4caffeine
ATCB01ACPlatelet aggregation inhibitors excl. heparinATC1-4aspirin
ATCN02BASalicylic acid and derivativesATC1-4aspirin
ATCN06BCXanthine derivativesATC1-4caffeine
FDASPLD014970XanthinesCHEMhas_chemical_structurecaffeine
FDASPLN0000175739Central Nervous System StimulantEPChas_epccaffeine
FDASPLN0000175790MethylxanthineEPChas_epccaffeine
FDASPLN0000175722Nonsteroidal Anti-inflammatory DrugEPChas_epcaspirin
FDASPLN0000175578Platelet Aggregation InhibitorEPChas_epcaspirin
FDASPLN0000175729Central Nervous System StimulationPEhas_pecaffeine
MEDRTD000082AcetaminophenCHEMhas_ingredientacetaminophen
MEDRTD001241AspirinCHEMhas_ingredientaspirin
MEDRTD002110CaffeineCHEMhas_ingredientcaffeine
MEDRTD001049ApneaDISEASEmay_treatcaffeine
MEDRTD001172Arthritis, RheumatoidDISEASEmay_treataspirin
MEDRTD001778Blood Coagulation DisordersDISEASEci_withaspirin
MEDRTD001791Blood Platelet DisordersDISEASEci_withaspirin
MEDRTD002544Cerebral InfarctionDISEASEmay_preventaspirin
MEDRTD002644ChickenpoxDISEASEci_withaspirin
MEDRTD002675Child, PreschoolDISEASEci_withaspirin
MEDRTD004342Drug HypersensitivityDISEASEci_withacetaminophen
MEDRTD004342Drug HypersensitivityDISEASEci_withaspirin
MEDRTD004342Drug HypersensitivityDISEASEci_withcaffeine
MEDRTD005221FatigueDISEASEmay_treatcaffeine
MEDRTD005334FeverDISEASEmay_preventacetaminophen
MEDRTD005334FeverDISEASEmay_treataspirin
MEDRTD005334FeverDISEASEmay_treatacetaminophen
MEDRTD005955Glucosephosphate Dehydrogenase DeficiencyDISEASEci_withacetaminophen
MEDRTD006073GoutDISEASEmay_treataspirin
MEDRTD006396HematemesisDISEASEci_withaspirin
MEDRTD006474Hemorrhagic DisordersDISEASEci_withaspirin
MEDRTD007223InfantDISEASEci_withaspirin
MEDRTD007249InflammationDISEASEmay_treataspirin
MEDRTD002546Ischemic Attack, TransientDISEASEmay_preventaspirin
MEDRTD008107Liver DiseasesDISEASEci_withacetaminophen
MEDRTD008551MelenaDISEASEci_withaspirin
MEDRTD009203Myocardial InfarctionDISEASEmay_preventaspirin
MEDRTD009298Nasal PolypsDISEASEci_withaspirin
MEDRTD010003OsteoarthritisDISEASEmay_treataspirin
MEDRTD010146PainDISEASEmay_treataspirin
MEDRTD010146PainDISEASEmay_preventacetaminophen
MEDRTD010146PainDISEASEmay_treatacetaminophen
MEDRTD010146PainDISEASEmay_preventaspirin
MEDRTD011225Pre-EclampsiaDISEASEmay_preventaspirin
MEDRTD011263Pregnancy Trimester, ThirdDISEASEci_withaspirin
MEDRTD012213Rheumatic FeverDISEASEmay_treataspirin
MEDRTN0000000160Cyclooxygenase InhibitorsMOAhas_moaaspirin
MEDRTN0000000133Enzyme InhibitorsMOAhas_moacaffeine
MEDRTN0000000108Prostaglandin Receptor AntagonistsMOAhas_moaacetaminophen
MEDRTN0000008322BronchodilationPEhas_pecaffeine
MEDRTN0000008331Cardiovascular Activity AlterationPEhas_pecaffeine
MEDRTN0000175724Central Nervous System Activity AlterationPEhas_peacetaminophen
MEDRTN0000008567Decreased Collecting Duct Water PermeabilityPEhas_pecaffeine
MEDRTN0000008831Decreased Platelet Activating Factor ProductionPEhas_peaspirin
MEDRTN0000008832Decreased Platelet AggregationPEhas_peaspirin
MEDRTN0000008836Decreased Prostaglandin ProductionPEhas_peaspirin
MEDRTN0000008836Decreased Prostaglandin ProductionPEhas_peacetaminophen
MEDRTN0000009006Decreased Thromboxane ProductionPEhas_peaspirin
MEDRTN0000009072Hypothalamic Endocrine Activity AlterationPEhas_peacetaminophen
MEDRTN0000009197Increased Central Nervous System Organized Electrical ActivityPEhas_pecaffeine
MEDRTN0000175725Peripheral Nervous System Activity AlterationPEhas_peacetaminophen
MEDRTN0000000026Hepatic MetabolismPKhas_pkaspirin
MEDRTN0000000026Hepatic MetabolismPKhas_pkacetaminophen
MEDRTN0000000042Renal ExcretionPKhas_pkaspirin
MEDRTN0000000042Renal ExcretionPKhas_pkacetaminophen

Properties#

Category, Property, Value table
CategoryPropertyValue
ATTRIBUTESAVAILABLE_STRENGTH250 MG / 250 MG / 65 MG
ATTRIBUTESGENERAL_CARDINALITYMULTI
ATTRIBUTESHUMAN_DRUGUS
ATTRIBUTESPRESCRIBABLEY
ATTRIBUTESRXNAV_HUMAN_DRUGUS
ATTRIBUTESSCHEDULE0
ATTRIBUTESTTYSBD
CODESMMSL_CODEBD3844
CODESRxCUI1303159
CODESSPL_SET_IDc280ca89-4fb5-4050-90ee-d706a550a1ef
NAMESPrescribable SynonymARTHRITEN Inflammatory Pain Formula 250 MG / 250 MG / 65 MG Oral Tablet
NAMESRXNAV_STRAPAP 250 MG / ASA 250 MG / Caffeine 65 MG Oral Tablet [Arthriten Inflammatory Pain]
NAMESRxNorm Nameacetaminophen 250 MG / aspirin 250 MG / caffeine 65 MG Oral Tablet [Arthriten Inflammatory Pain]
NAMESRxNorm SynonymAPAP 250 MG / ASA 250 MG / Caffeine 65 MG Oral Tablet [Arthriten Inflammatory Pain]
NAMESRxNorm SynonymArthriten Inflammatory Pain (APAP 250 MG / ASA 250 MG / caffeine 65 MG) Oral Tablet
SOURCESSourceMetathesaurus FDA Structured Product Labels
SOURCESSourceMultum MediSource Lexicon